Hypertension Flashcards
Furosemide
LOOP DIURETICS
Route: Oral/IV
Onset:
- oral: 60 minutes
- IV: 5 minutes
Adverse effects:
- dehydration
- electrolyte abnormalities
- hypotension
- ototoxicity
- hyperuricemia
Considerations: Avoid taking before bedtime Monitor urine output Watch for signs of dehydration Give IV doses SLOWLY to avoid ototoxicity Caution in patients with a sulfa allergy
Toresemide
LOOP DIURETICS
Route: Oral/IV
Onset:
- oral: 60 minutes
- IV: 5 minutes
Adverse effects:
- dehydration
- electrolyte abnormalities
- hypotension
- ototoxicity
- hyperuricemia
Considerations: Avoid taking before bedtime Monitor urine output Watch for signs of dehydration Give IV doses SLOWLY to avoid ototoxicity Caution in patients with a sulfa allergy
Bumetanide
LOOP DIURETICS
Route: Oral/IV
Onset:
- oral: 60 minutes
- IV: 5 minutes
Adverse effects:
- dehydration
- electrolyte abnormalities
- hypotension
- ototoxicity
- hyperuricemia
Considerations: Avoid taking before bedtime Monitor urine output Watch for signs of dehydration Give IV doses SLOWLY to avoid ototoxicity Caution in patients with a sulfa allergy
Ethacrynic acid
LOOP DIURETICS
Route: Oral/IV
Onset:
- oral: 60 minutes
- IV: 5 minutes
Adverse effects:
- dehydration
- electrolyte abnormalities
- hypotension
- ototoxicity
- hyperuricemia
Considerations:
Monitor urine output
Can be given safely to patients with a sulfa allergy
Hydrochlorothiazide
THIAZIDE DIURETICS
Route: Oral
Onset:
1-2 hours
Adverse effects: Dehydration Electrolyte abnormalities Hyperglycemia Hyperuricemia
Considerations: Avoid dosing before bedtime All agents equally effective Monitor for ADEs especially related to electrolyte abnormalities Caution in patients with a sulfa allergy
Chlorothiazide
THIAZIDE DIURETICS
Route: Oral/IV
Onset:
1-2 hours
Adverse effects: Dehydration Electrolyte abnormalities Hyperglycemia Hyperuricemia
Considerations: Avoid dosing before bedtime All agents equally effective Monitor for ADEs especially related to electrolyte abnormalities Caution in patients with a sulfa allergy
Chlorthalidone
THIAZIDE DIURETICS
Route:Oral
Onset:
1-2 hours
Adverse effects: Dehydration Electrolyte abnormalities Hyperglycemia Hyperuricemia
Considerations: Avoid dosing before bedtime All agents equally effective Monitor for ADEs especially related to electrolyte abnormalities Caution in patients with a sulfa allergy
Metolazone
THIAZIDE DIURETICS
Route: Oral
Onset:
1-2 hours
Adverse effects: Dehydration Electrolyte abnormalities Hyperglycemia Hyperuricemia
Considerations: Avoid dosing before bedtime All agents equally effective Monitor for ADEs especially related to electrolyte abnormalities Caution in patients with a sulfa allergy
Loop Diuretics
Most effective class of diuretics
Mechanism of action:
- block sodium and chloride reabsorption in the ascending Loop of Henle
- 20% of Na and Cl typically reabsorbed here, inhibition leads to profound diuresis
Loop Diuretics
Indications: Congestive heart failure Pulmonary edema Peripheral edema Hypertension
Thiazide diuretics
-Lesser diuretic effect than loop diuretics
Hydrochlorathiazide (PO)
Cholorothiazide (PO or IV)
Chlorthalidone (PO)
Metolazone (PO)
▷Mechanism of action:
○Block reabsorption of Na+ and Cl- at the early segment of the distal convoluted tubule (DCT)
○10% of Na and Cl reabsorbed from DCT; inhibition leads to diuresis
Potassium sparing diuretics
Therapeutic effects:
○Small amount of diuresis
○Decrease potassium excretion
○Reduce cardiac remodeling
Renal physiology
PATHO
Filtration
•Occurs at the glomerulus
•All small molecules get filtered
Reabsorption
•99% of water, electrolytes and nutrients undergo reabsorption via active transport
Active tubular secretion
•Located in proximal convoluted tubule
•Excrete products into lumen of nephron
Amiloride and Triamterene
Administration: Oral
NON-ALDOSTERONE POTASSIUM SPARING DIURETICS
Mechanism of action:
•Direct inhibitor of the Na/K ion exchange transporter
•Increased excretion of sodium and retention of potassium
Indications:
•Hypertension
•Edema
Adverse effects
•Hyperkalemia
DDI:
•Thiazide and loop diuretics
•Agents that raise potassium
Spironolactone
Administration: Oral
Mechanism of action
•blocks aldosterone in the DCT
•aldosterone typically causes sodium retention and potassium excretion
•Increased excretion of sodium and retention of potassium
Indications: •Hypertension and edema •Heart failure •Acne •Polycystic ovarian syndrome
Adverse effects
•Hyperkalemia
•Endocrine effects
DDI:
•Thiazide and loop diuretics
•Agents that raise potassium
Renal physiology (patho)
Three basic functions:
Cleansing of extracellular fluid (ECF) and maintenance of ECF volume and composition
Maintenance of acid-base balance
Excretion of metabolic wastes (drugs/toxins
Mannitol
Osmotic diuretic made of a 6-carbon sugar
Route: IV
- *Inspect product prior to administration**
- Mannitol can crystalize
- Must be administered through 0.22 micron filter to remove microcrystals
Mechanism of action:
- Filtered by the glomerulus
- Does NOT undergo reabsorption and remains in the lumen
- Increased osmotic pressure keeps water from being reabsorbed
Indications:
-Reduce elevated intracranial and intraocular pressures
Adverse effects:
Edema
Electrolyte imbalances
Renin-Angiotensin-Aldosterone-System (RAAS)
patho
The RAAS system plays critical role in regulating blood pressure, blood volume and fluids and electrolytes
Related drug classes: Angiotensin converting enzyme inhibitors (ACE-i) Angiotensin II receptor blockers (ARB) Direct renin inhibitors (DRI) Aldosterone antagonists
RAAS KEY COMPOUNDS
Angiotensin
Aldosterone
Renin
Angiotensin
A RAAS
Three subtypes
Angiotensin I: inactive; converted into angiotensin II by angiotensin-converting enzyme (ACE)
Angiotensin II: Powerful vasoconstrictor (increases blood pressure) Stimulates release of aldosterone (increases blood pressure) Causes remodeling and hypertrophy of the myocardium
Angiotensin III: effects incompletely understood
Aldosterone
RAAS
Stimulates Na+ retention and K+ excretion in the distal convoluted tubule
Na+ retention leads to water retention which increases blood pressure
Causes pathologic remodeling and hypertrophy of the myocardium
Renin
RAAS
Enzyme that starts the whole RAAS pathway
Produced by the kidney in response to:
Low blood pressure
Low blood volume
Low blood sodium content
Renin release is SUPPRESSED when the above factors return to normal
Angiotensin Converting Enzyme Inhibitors (ACE-I)
LISINOPRIL ENALAPRIL ENALAPRILAT CAPTOPRIL BENAZEPRIL
Very effective for treating
Hypertension
Heart failure
Diabetic nephropathy
Generally well-tolerated
All agents are equally efficacious
ACE-inhibitors
-pril meds
Pharmacokinetics:
- All administered orally, EXCEPT enalaprilat is IV
- Long half-lives EXCEPT captopril
- Renally excreted
Adverse effects
- First-dose hypotension
- Dry cough
- hyperkalemia (high potassium levels)
- Renal failure in patients with bilateral renal artery stenosis
- Fetal injury
- Angioedema
DDI: Diuretics Antihypertensive agents Drugs that raise potassium Lithium NSAIDs